Protein's New Role Discovered in Autoimmune DiseaseJanuary 03, 2008BIRMINGHAM, Ala. - Investigators at the University of Alabama at Birmingham (UAB) have identified the previously unknown role of a chemical 'messenger' leading to autoimmune disorders like rheumatoid arthritis and lupus. The messenger is the naturally occurring chemical interleukin 17 (IL-17), an immunity protein. UAB researchers pinpointed an unknown role IL-17 plays in autoimmune and inflammatory responses, aside from its commonly known effects within immunity. Future research will home in on IL-17's unwanted actions and preserve its benefits within the immune system.
The new findings are published in the journal Nature Immunology. In the study, UAB scientists blocked messenger signals from the IL-17 protein to the immune system of mice. This disruption significantly reduced the number of white blood cells, namely disease-causing B cells, clustered in the mice's spleen. The number of B-cell clusters dropped from 17 percent to 2 percent when the IL-17 protein signals were blocked, the study authors said. The drop was a clear sign that IL-17 plays a major role on shaping B cells' ability to create more and more disease-causing antibodies. "The effect of IL-17 to slow down B cells, thereby enhancing their interaction with other immune regulatory cells a new and exciting discovery," said John D. Mountz, M.D., Ph.D., UAB professor of medicine and senior author on the study. "This is surprising since previously IL-17 was thought to increase, but not decrease, cell motion. Now the effects of IL-17 on B cells can be explored more fully," Mountz said. Many types of B cells make up the human immune system, which is regulated to sense and fight infection without attacking normal, healthy tissue. In autoimmune diseases that regulatory process becomes imbalanced. "Knowing more about IL-17's ability to regulate unwanted B-cell migration will generate new ideas in the ongoing search for better drug targets in preventing and treating autoimmune disease," said Hui-Chen Hsu, Ph.D. an assistant professor in the UAB Division of Clinical Immunology and Rheumatology and lead author on the study. The research team included UAB investigators from the departments of Medicine, Cell Biology, Pathology, Microbiology and Dermatology and from Children's Hospital of Pittsburgh and the University of Tennessee Health Science Center in Memphis. Funding for the study came from the Arthritis Foundation, the American College of Rheumatology, the U.S. Department of Veterans Affairs, the National Institutes of Health and Tokyo-based Daiichi Sankyo Co., Ltd. University of Alabama at Birmingham (UAB) | |||||||||||||||||||||
|
Related Autoimmune Current Events and Autoimmune News Articles JDRF funded research shows promise for prevention, reversal of type 1 diabetes Researchers at the University of California, San Francisco have reported that two common cancer drugs have been used to block and reverse type 1 diabetes in mice. Penn Scientists Show How Body Determines Optimal Amount of Germ-Fighting B Cells Researchers at the University of Pennsylvania School of Medicine can now explain how the body determines whether there are enough mature B-cells in the blood stream at any one time. These are the cells that produce antibodies against germs to fight infections. Previously unknown immune cell may help those with Crohn's and colitis The tonsils and lymphoid tissues in the intestinal tract that help protect the body from external pathogens are the home base of a rare immune cell newly identified by researchers at Washington University School of Medicine in St. Louis. Lung airway cells activate vitamin D and increase immune response Vitamin D is essential to good health but needs to be activated to function properly in the human body. Until recently, this activation was thought to happen primarily in the kidneys, but a new University of Iowa study finds that the activation step can also occur in lung airway cells. Mayo Clinic's new imaging technology accurately identifies a broad spectrum of liver disease A new study shows that an imaging technology developed by Mayo Clinic researchers can identify liver fibrosis with high accuracy and help eliminate the need for liver biopsies. Liver fibrosis is a common condition that can lead to incurable cirrhosis if not treated in time. Type-1 diabetes not so much bad genes as good genes behaving badly, Stanford research shows Investigators combing the genome in the hope of finding genetic variants responsible for triggering early-onset diabetes may be looking in the wrong place, new research at the Stanford University School of Medicine suggests. Geisinger research: Antimalarial drug prevents diabetes in arthritis patients The use of an antimalarial medication may prevent the onset of diabetes in patients with rheumatoid arthritis, new Geisinger research shows. Toxic Bile Damages the Liver Researchers at the Heidelberg University Hospital have discovered a new genetic disease that can lead to severe liver damage. Because a protective component of the bile is missing, the liver cells are exposed to the toxic components of the bile, resulting in cirrhosis of liver, a transformation of liver cells into connective tissue with a gradual loss of liver function. A reversal of thinking: How women with lupus can increase chance for healthy pregnancies In the not so distant past, women with systemic lupus erythematosus (SLE), an autoimmune disease, were advised not to have children, and if they became pregnant, to have therapeutic abortions to prevent severe flares of their lupus. First international guidelines for treatment of psoriatic arthritis Rheumatologists, dermatologists, and patient advocates have come together to publish the first-ever international guidelines for the treatment of psoriatic arthritis, a disease that mainly affects people who have psoriasis but also some people without it. More Autoimmune Current Events and Autoimmune News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||